A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
GlaxoSmithKline
GlaxoSmithKline
Deciphera Pharmaceuticals, LLC
Cogent Biosciences, Inc.
Deciphera Pharmaceuticals, LLC
Jiangsu HengRui Medicine Co., Ltd.
AB Science
Deciphera Pharmaceuticals, LLC
Blueprint Medicines Corporation
Bayer
AB Science
Novartis
Novartis
Novartis
INSYS Therapeutics Inc
Infinity Pharmaceuticals, Inc.
Novartis
Pfizer
Pfizer